title: [Update coronary artery disease: important progresses in acute and chronic therapy].
authors.affiliation: Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin III, Stuttgart. anastasios.athanasiadis@rbk.de
authors.forename: Anastasios
authors.initials: A
authors.lastname: Athanasiadis
authors.forename: Udo
authors.initials: U
authors.lastname: Sechtem
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D000787:Angina Pectoris / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D001552:Benzazepines / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D061345:Early Medical Intervention; D006801:Humans; D000077550:Ivabradine; D009203:Myocardial Infarction / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D000069458:Ranolazine; D015996:Survival Rate; D015912:Thrombolytic Therapy
chemical_list: D000083:Acetanilides; D001552:Benzazepines; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D000077550:Ivabradine; D000069458:Ranolazine